![ALPROLIX® [coagulation factor IX (recombinant), Fc fusion protein], lyophilized powder for solution for intravenous injection. Prescribing Information ALPROLIX® [coagulation factor IX (recombinant), Fc fusion protein], lyophilized powder for solution for intravenous injection. Prescribing Information](https://products.sanofi.us/Alprolix/alp0b-0002-03.jpg)
ALPROLIX® [coagulation factor IX (recombinant), Fc fusion protein], lyophilized powder for solution for intravenous injection. Prescribing Information
![ALPROLIX® [coagulation factor IX (recombinant), Fc fusion protein], lyophilized powder for solution for intravenous injection. Prescribing Information ALPROLIX® [coagulation factor IX (recombinant), Fc fusion protein], lyophilized powder for solution for intravenous injection. Prescribing Information](https://products.sanofi.us/Alprolix/alp0b-0002-02.jpg)
ALPROLIX® [coagulation factor IX (recombinant), Fc fusion protein], lyophilized powder for solution for intravenous injection. Prescribing Information
![Frontiers | Status of Recombinant Factor VIII Concentrate Treatment for Hemophilia A in Italy: Characteristics and Clinical Benefits Frontiers | Status of Recombinant Factor VIII Concentrate Treatment for Hemophilia A in Italy: Characteristics and Clinical Benefits](https://www.frontiersin.org/files/Articles/484310/fmed-06-00261-HTML-r1/image_m/fmed-06-00261-t003.jpg)
Frontiers | Status of Recombinant Factor VIII Concentrate Treatment for Hemophilia A in Italy: Characteristics and Clinical Benefits
![ALPROLIX® [coagulation factor IX (recombinant), Fc fusion protein], lyophilized powder for solution for intravenous injection. Prescribing Information ALPROLIX® [coagulation factor IX (recombinant), Fc fusion protein], lyophilized powder for solution for intravenous injection. Prescribing Information](https://products.sanofi.us/Alprolix/alp0b-0002-01.jpg)
ALPROLIX® [coagulation factor IX (recombinant), Fc fusion protein], lyophilized powder for solution for intravenous injection. Prescribing Information
![Special Report—2 years after sluggish 2016, new drug approvals hit their stride in 2018 | Fierce Biotech Special Report—2 years after sluggish 2016, new drug approvals hit their stride in 2018 | Fierce Biotech](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1545151750/Industria_Novartis_wiki_andrew_flickr.jpg/Industria_Novartis_wiki_andrew_flickr.jpg?VersionId=NP41nRlcOzLThEs9iJuaEW6QwSgGyZKI)
Special Report—2 years after sluggish 2016, new drug approvals hit their stride in 2018 | Fierce Biotech
![ALPROLIX® [coagulation factor IX (recombinant), Fc fusion protein], lyophilized powder for solution for intravenous injection. Prescribing Information ALPROLIX® [coagulation factor IX (recombinant), Fc fusion protein], lyophilized powder for solution for intravenous injection. Prescribing Information](https://products.sanofi.us/Alprolix/alp0b-0002-04.jpg)